Apixaban Twice Daily vs Rivaroxaban Once Daily for the Treatment of Venous Thromboembolism: A randomised controlled trial (COBRRA)
GA ID:
Agency:
Department of Health and Aged Care
Publish Date:
5-Feb-2020
Category:
Health and Medical Research
Grant Term:
1-Feb-2020
to
31-Jan-2024
Value (AUD):
$1,057,839.75
Recipient Name:
University of Sydney
Last Updated:
5-Feb-2020 12:34 pm (ACT Local Time)